Skip to article
Astra

Hereditary GI Oncology

Familial Adenomatous Polyposis

Familial adenomatous polyposis requires early APC-directed family testing, intensive colorectal surveillance, timely risk-reducing colectomy, and lifelong upper gastrointestinal assessment with ampullary visualization to prevent colorectal and duodenal malignancy.

Clinical question: How should physicians diagnose, surveil, and select risk-reducing surgery for patients with familial adenomatous polyposis?

Diagnosis

Establish APC-associated polyposis and identify relatives who need early surveillance

Genotype directs predictive testing and determines whether intensive surveillance should begin in childhood.

Establish an APC-associated polyposis condition by identifying a heterozygous germline pathogenic APC variant. Classic and attenuated FAP are APC-associated phenotypes; gastric adenocarcinoma and proximal polyposis of the stomach is also included in the APC-associated spectrum. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

A clinical phenotype of more than 100 colorectal adenomatous polyps supports classic FAP; fewer than 100 adenomas with a family history of FAP also supports the diagnosis. Attenuated FAP generally has fewer than 100 adenomas, later polyp development, and a more proximal colonic distribution. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect TopicsccjmDetecting and managing hereditary colorectal cancer syndromes in ...

For a known familial APC pathogenic variant, offer predictive molecular testing to at-risk relatives early enough to determine whether childhood surveillance is necessary. In confirmed FAP after predictive testing, colonic surveillance should normally begin at age 12-14 years; GeneReviews recommends colonoscopy every 1-2 years beginning at age 10-15 years for classic FAP. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | GutPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

When a patient has multiple colorectal adenomas but no germline APC or MUTYH variant, retain concern for APC mosaicism rather than labeling the condition sporadic without further assessment. Low-level APC mosaicism accounts for a substantial fraction of otherwise unexplained adenomatous polyposis, and first-degree relatives may warrant colonoscopic risk assessment at referral or again at age 50 years, although this latter recommendation lacked guideline consensus. BMJGuidelines for the management of hereditary colorectal cancer ... - GutBMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | Gut

Phenotype and surveillance distinctions in APC-associated polyposis. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | GutScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect TopicsPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Clinical settingActionable interpretationNext surveillance action
Classic FAP phenotypeMore than 100 colorectal adenomatous polyps supports clinical FAP. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect TopicsBegin colonoscopy at age 10-15 years; repeat every 1-2 years. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Attenuated FAP phenotypeUsually fewer than 100 adenomas, often with later onset and proximal predominance. ccjmDetecting and managing hereditary colorectal cancer syndromes in ...Begin colorectal surveillance in late adolescence. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Confirmed FAP by predictive testingAPC pathogenic variant identifies patients at high colorectal and upper GI risk. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfColonic surveillance may be individualized to phenotype every 1-3 years. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | Gut
Multiple metachronous adenomas after clearanceAt least 10 metachronous adenomas indicates substantial recurrent adenoma burden. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | GutAnnual colonoscopy; extend to every 2 years only if no subsequent lesion is 10 mm or larger. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | Gut

Colorectal cancer prevention

Use colonoscopic burden and histology to time colectomy

The operative decision is driven by endoscopic controllability and dysplasia, not by a fixed polyp count alone.

Continue colonoscopic surveillance while adenomas remain endoscopically manageable, but refer for colectomy planning when multiple adenomas larger than 10 mm cannot reasonably be removed, adenoma number increases substantially between examinations, high-grade dysplasia is identified, or innumerable diminutive adenomas prevent adequate colonic surveillance. Limited endoscopic access or inability to adhere to surveillance is also a relative indication for colectomy. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

Colectomy is the preventive standard for classic FAP because it reduces colorectal cancer risk. The operation should be selected and timed through a colorectal surgery team able to integrate rectal polyp burden, endoscopic feasibility, patient reliability for lifelong surveillance, and competing extracolonic disease. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

Surveillance materially changes outcomes. In a systematic review, symptomatic FAP presentation was associated with colorectal cancer in 33.6%-66.2% of patients versus 3.8%-9.4% among those under surveillance; surveillance delayed colorectal cancer development by up to 16 years and improved mean survival by up to 12 years. BMJRole of endoscopy in patients with familial adenomatous polyposis

Do not defer indicated surgery because pharmacologic polyp regression occurs. NSAIDs and erlotinib have reduced adenoma burden in studies, but no agent is FDA-approved for FAP chemoprevention because reduction in later cancer risk remains unclear. Colectomy or proctocolectomy remains initial standard care. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfWolters KluwerCombination of Sulindac and Eflornithine Delays... - Lippincott

Colorectal decision triggers for FAP. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
FindingInterpretationAction
Adenomas controlled by endoscopic resectionColon remains adequately surveillable. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfContinue phenotype-directed colonoscopic surveillance. BMJGuidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | GutPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Multiple adenomas larger than 10 mm not reasonably removableEndoscopic clearance is inadequate. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfRefer for risk-reducing colectomy planning. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
High-grade dysplasiaAdvanced neoplastic change raises urgency of definitive colorectal management. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfProceed with colorectal surgical evaluation for colectomy. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Innumerable diminutive adenomas, poor access, or inability to comply with surveillanceAdequate cancer surveillance cannot be ensured. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfTreat as a relative indication for colectomy. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

Duodenal and gastric risk

Perform lifelong upper GI surveillance with ampullary assessment

After colorectal risk reduction, duodenal and periampullary neoplasia become central management targets.

Perform esophagogastroduodenoscopy with visualization of the ampulla of Vater by age 20-25 years or before colon surgery. Upper GI surveillance should not omit ampullary inspection, because duodenal and ampullary adenomas can progress independently of the colorectal phenotype. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfWolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journal

Stage duodenal adenomatosis using the Spigelman classification, which is recommended for risk stratification and has demonstrated excellent interobserver reliability among experienced endoscopists (intraclass correlation coefficient 0.95, 95% CI 0.91-0.98). In advanced Spigelman stage, consider complete small-bowel visualization. Wolters KluwerValidation of the Endoscopic Part of the Spigelman... : Official journal of the American College of Gastroenterology | ACGPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

The clinical stakes are substantial: duodenal adenomas develop in an estimated 88%-98% of patients with FAP, and estimated duodenal cancer risk reaches 18% by age 75 years. High-risk duodenal adenoma features are reported in 50% of patients by age 70 years. BMJRole of endoscopy in patients with familial adenomatous polyposis

Endoscopically remove duodenal polyps larger than 10 mm when feasible. Repeated endoscopic resection and ampullectomy can downstage severe disease, but high-grade dysplasia or unresectable lesions should trigger evaluation for radical surgery, including duodenectomy or pancreaticoduodenectomy when malignancy is threatening. Wolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports JournalWolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & Rectum

Upper GI escalation in FAP. Wolters KluwerValidation of the Endoscopic Part of the Spigelman... : Official journal of the American College of Gastroenterology | ACGWolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & RectumWolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports JournalScienceDirectGastric polyposis and risk of gastric cancer in patients with familial adenomatous polyposisPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Endoscopic or histologic findingRisk interpretationNext action
FAP without prior upper GI assessmentUpper GI neoplasia requires dedicated surveillance. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfEGD with ampullary visualization by age 20-25 years or before colon surgery. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Advanced duodenal adenomatosisSpigelman staging supports risk stratification; advanced disease may justify complete small-bowel visualization. Wolters KluwerValidation of the Endoscopic Part of the Spigelman... : Official journal of the American College of Gastroenterology | ACGPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfIncrease expert endoscopic assessment and consider complete small-bowel evaluation. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
Duodenal polyp larger than 10 mmLarger lesions warrant therapeutic endoscopic consideration. Wolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports JournalRemove endoscopically when feasible. Wolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journal
High-grade dysplasia or unresectable duodenal/ampullary lesionMalignancy risk may exceed what iterative endoscopic therapy can control. Wolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & RectumRefer for radical surgical evaluation, including duodenectomy or pancreaticoduodenectomy. Wolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & Rectum
Gastric high-grade dysplasia or gastric cancerHigh-grade dysplasia carries a 20% 10-year cumulative gastric cancer incidence in one cohort. ScienceDirectGastric polyposis and risk of gastric cancer in patients with familial adenomatous polyposisObtain surgical evaluation; total gastrectomy is indicated for gastric polyps with high-grade dysplasia or cancer. Wolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journal

Gastric polyposis that changes management

During EGD, characterize gastric polyps and obtain histology when dysplasia is suspected. In a 337-patient FAP cohort, the 10-year cumulative gastric cancer incidence was 0% with no polyps, 1% with polyps, 6% with low-grade dysplasia, 11% with polyps 2 cm or larger, and 20% with high-grade dysplasia; high-grade dysplasia and polyps at least 2 cm were strongly associated with gastric cancer. ScienceDirectGastric polyposis and risk of gastric cancer in patients with familial adenomatous polyposis

Refer patients with gastric high-grade dysplasia or cancer for surgical evaluation. Total gastrectomy with Roux-en-Y esophagojejunostomy is indicated when gastric polyps harbor high-grade dysplasia or cancer. Wolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journal

Extracolonic disease

Recognize desmoid disease and pediatric hepatoblastoma risk

Extraintestinal manifestations can alter surgical timing and prompt targeted evaluation.

Maintain a low threshold to evaluate new abdominal mass symptoms in FAP for intra-abdominal desmoid tumor, particularly after abdominal surgery. Desmoid tumors are locally aggressive and infiltrative but rarely metastasize; reported FAP incidence is 10%-20%, and family history, surgery, and APC mutation are recognized risk factors. facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACSfacs[PDF] Jejunal Desmoid Tumor after Roux-en-Y Gastric Bypass Mimicking ...

For children known to carry an APC pathogenic variant or at 50% familial risk, annual hepatoblastoma screening from birth through age 5 years has been recommended. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect Topics

Do not automatically infer FAP from an isolated desmoid tumor. Although 5%-15% of desmoids are associated with FAP, reported yield of identifying FAP among patients with intra-abdominal or truncal desmoids without prior history was 4%-5%; a selective colonoscopy or genetic-testing strategy is therefore more appropriate than universal screening. facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACS

Targeted extracolonic actions in FAP. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect Topicsfacs[PDF] Jejunal Desmoid Tumor after Roux-en-Y Gastric Bypass Mimicking ...facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACS
Clinical scenarioActionReason
Known APC pathogenic variant or 50% FAP risk, birth through age 5 yearsPerform annual hepatoblastoma screening. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect TopicsThis is the recommended pediatric surveillance window. ScienceDirectFamilial Adenomatous Polyposis - an overview | ScienceDirect Topics
FAP with postoperative or new abdominal mass symptomsEvaluate for intra-abdominal desmoid tumor. facs[PDF] Jejunal Desmoid Tumor after Roux-en-Y Gastric Bypass Mimicking ...facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACSFAP-associated desmoids are frequently intra-abdominal and surgery is a risk factor. facs[PDF] Jejunal Desmoid Tumor after Roux-en-Y Gastric Bypass Mimicking ...facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACS
Isolated intra-abdominal or truncal desmoid without known FAPUse selective, phenotype-driven colonoscopy or genetic testing rather than universal FAP screening. facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACSDetection yield for occult FAP is reported at 4%-5%. facsJejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACS

Care coordination

Build surveillance around irreversible risk and procedural feasibility

Management requires parallel colorectal, upper GI, surgical, and family-based follow-up.

At each surveillance encounter, document three variables that change management: colorectal adenoma size and removability, interval change in adenoma number, and dysplasia grade. These determine whether continued endoscopic control remains reasonable or colectomy should be advanced. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf

Coordinate colorectal and upper GI planning rather than treating them as sequential problems. EGD should occur by age 20-25 years or before colon surgery, and advanced duodenal disease may require complete small-bowel visualization or referral for therapeutic endoscopy and surgery. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfWolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & Rectum

After colorectal surgery, continue surveillance of remaining at-risk gastrointestinal mucosa and maintain upper GI monitoring. Post-prophylactic adenocarcinomas and neoplastic change in ileal pouches have been reported, while duodenal cancer becomes a major malignancy after colectomy. BMJGuidelines for the management of hereditary colorectal cancer ... - GutWolters KluwerEndoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journal

Longitudinal checkpoint framework for FAP. BMJGuidelines for the management of hereditary colorectal cancer ... - GutWolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & RectumPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
CheckpointRequired decisionEscalation trigger
ColonoscopyCan the colon still be completely and reliably surveilled? PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfUnremovable adenomas larger than 10 mm, high-grade dysplasia, accelerating burden, or inadequate surveillance. PubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelf
EGD with ampullary visualizationWhat is the duodenal and ampullary neoplasia burden? Wolters KluwerValidation of the Endoscopic Part of the Spigelman... : Official journal of the American College of Gastroenterology | ACGPubMedAPC-Associated Polyposis Conditions - GeneReviews® - NCBI BookshelfAdvanced disease, high-grade dysplasia, or unresectable lesions. Wolters KluwerSurveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & Rectum
After prophylactic colorectal surgeryWhich residual mucosa remains at risk? BMJGuidelines for the management of hereditary colorectal cancer ... - GutNew neoplasia in retained or pouch mucosa requires continued endoscopic management. BMJGuidelines for the management of hereditary colorectal cancer ... - Gut

References

  1. Guidelines for the management of hereditary colorectal cancer ... - Gutgut.bmj.com · gut.bmj.com
  2. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) | Gutgut.bmj.com · gut.bmj.com
  3. The Use and Interpretation of Commercial APC Gene Testing for ...www.nejm.org · www.nejm.org
  4. The Molecular Basis of Turcot's Syndromewww.nejm.org · www.nejm.org
  5. Primary Chemoprevention of Familial Adenomatous Polyposis with ...www.nejm.org · www.nejm.org
  6. The management of gastric polyps - Gutgut.bmj.com · gut.bmj.com
  7. Multiple Colorectal Adenomas, Classic Adenomatous Polyposis ...www.nejm.org · www.nejm.org
  8. British Society of Gastroenterology guidelines on colorectal ... - Gutgut.bmj.com · gut.bmj.com
  9. Role of endoscopy in patients with familial adenomatous polyposisfg.bmj.com · fg.bmj.com
  10. Familial Adenomatous Polyposis - an overview | ScienceDirect Topicssciencedirect.com · sciencedirect.com
  11. Validation of the Endoscopic Part of the Spigelman... : Official journal of the American College of Gastroenterology | ACGjournals.lww.com · journals.lww.com
  12. Surveillance of Duodenal Polyposis in Familial... : Diseases of the Colon & Rectumjournals.lww.com · journals.lww.com
  13. Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  14. Endoscopic Surveillance of Duodenal Polyposis... : ACG Case Reports Journaljournals.lww.com · journals.lww.com
  15. Gastric polyposis and risk of gastric cancer in patients with familial adenomatous polyposiswww.sciencedirect.com · www.sciencedirect.com
  16. Combination of Sulindac and Eflornithine Delays... - Lippincottjournals.lww.com · journals.lww.com
  17. Detecting and managing hereditary colorectal cancer syndromes in ...www.ccjm.org · www.ccjm.org
  18. [PDF] Jejunal Desmoid Tumor after Roux-en-Y Gastric Bypass Mimicking ...www.facs.org · www.facs.org
  19. Jejunal Desmoid Tumor After Roux-en-Y Gastric Bypass Mimicking GIST | ACSwww.facs.org · www.facs.org
  20. Hereditary Gastrointestinal Cancer Syndromes: Role of Imaging in ...pubs.rsna.org · pubs.rsna.org
  21. APC-Associated Polyposis Conditions - GeneReviews® - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. Genetic characterization of the APC locus involved in familial adenomatous polyposis - Gastroenterologywww.gastrojournal.org · www.gastrojournal.org
  23. ASCO/SSO Review of Current Role of Risk-Reducing Surgery in ...ascopubs.org · ascopubs.org
  24. [PDF] Colorectal Cancer Glossary - CDC Archivearchive.cdc.gov · archive.cdc.gov